Bayer plans US expansion despite blood thinner drug setback
Medlarge
Short News
![Bayer plans US expansion despite blood thinner drug setback](https://i0.wp.com/medlarge.com/wp-content/uploads/2023/06/living-kidney-donor-transplant-2x.jpg?fit=800%2C560&ssl=1)
Germany's Bayer will continue its expansion into the U.S. despite its November announcement that its promising blood thinner candidate failed to demonstrate superiority over a competing medicine, the drugmaker's pharmaceuticals head Stefan Oelrich said on Monday.
Source(s): Read More
Comments